The Latest
-
Trump tariffs
J&J expects tariff charge of $400M this year
CFO Joe Wolk, who revealed the figure Tuesday morning on CNBC, told investors the charge was primarily in the healthcare giant’s medtech business.
-
Edwards receives CE mark for Sapien M3 mitral valve replacement device
The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s Mitraclip.
-
Trump tariffs
US launches probe that could set stage for pharma tariffs
The Commerce Department has begun a so-called Section 232 investigation into the national security effects of the U.S. importing pharmaceuticals and their starting materials.
Updated April 14, 2025 -
Trump tariffs
US launches probe into semiconductor imports
The Section 232 investigation comes ahead of anticipated tariffs on the industry.
-
J&J completes first surgeries with Ottava robot
Johnson & Johnson plans to seek a U.S. indication for multiple general surgery procedures, including gastric bypass, which was performed in the clinical trial.
-
Trump tariffs
Tariffs top of mind for medtech firms this earnings season
GE Healthcare and Medtronic said they are preparing mitigation plans as they assess the potential ramifications of Trump’s tariff policies.
-
The image by Coolcaesar is licensed under CC BY-SA 4.0
Cepheid to lay off 167 people in California
The company laid off more than 1,300 people in California in 2023 and 2024 as respiratory sales fell from the peak hit during the pandemic.
-
Trump tariffs
Pharma bosses face down investor angst on tariffs, HHS chaos
As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S. tariffs on their products.
-
Late-stage digital health funding rebounds in Q1: Rock Health
The median deal size for late-stage funding rounds was $105 million, nearly double the $55 million check size across 2024.
-
Retrieved from Intuitive Surgical on April 11, 2025
Intuitive wins FDA clearance for single-port robotic surgery stapler
CFO Jamie Samath said in January that the stapler clearance would trigger the start of “broad commercial efforts” for the single-port system.
-
Trump tariffs
Tariff turmoil: Hospitals, device makers welcome pause, but fear long-term pain
Healthcare providers and medtech companies still face pressure to find ways to offset potential supply chain shocks despite the latest about-face in President Donald Trump’s tariff wars.